Stemline Therapeutics, Inc. financial reports, Stemline Therapeutics, Inc. annual revenue in 2024. When does Stemline Therapeutics, Inc. report revenue?
Stemline Therapeutics, Inc. total revenue, net income and dynamics of changes in US dollar today
Stemline Therapeutics, Inc. current income in US dollar. The dynamics of Stemline Therapeutics, Inc. net income fell by -772 352 $. The assessment of the dynamics of Stemline Therapeutics, Inc. net income was made in comparison with the previous report. Net income, revenue and dynamics - the main financial indicators of Stemline Therapeutics, Inc.. Stemline Therapeutics, Inc. online financial report chart. The financial schedule of Stemline Therapeutics, Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. Stemline Therapeutics, Inc. net income is shown in blue on the graph.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019
5 048 590 $
-
-27 407 266 $
-
31/12/2018
0 $
-
-26 634 914 $
-
30/09/2018
0 $
-100 % ↓
-21 043 996 $
-
30/06/2018
500 000 $
+67 % ↑
-18 928 703 $
-
31/03/2018
0 $
-
-18 416 753 $
-
31/12/2017
0 $
-
-21 749 301 $
-
30/09/2017
299 397 $
-
-16 056 147 $
-
30/06/2017
299 401 $
-
-15 456 936 $
-
Show:
to
Stemline Therapeutics, Inc. financial report charts
The dates of the latest financial statements of Stemline Therapeutics, Inc.: 30/06/2017, 31/12/2018, 31/03/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Stemline Therapeutics, Inc. for today is 31/03/2019. Gross profit Stemline Therapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Stemline Therapeutics, Inc. is -11 990 960 $
Stemline Therapeutics, Inc. quarterly report dates
Cost of revenue Stemline Therapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Stemline Therapeutics, Inc. is 17 039 550 $ Total revenue Stemline Therapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Stemline Therapeutics, Inc. is 5 048 590 $ Operating revenue Stemline Therapeutics, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Stemline Therapeutics, Inc. is 5 048 590 $
Operating income Stemline Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Stemline Therapeutics, Inc. is -27 944 928 $ Net income Stemline Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Stemline Therapeutics, Inc. is -27 407 266 $ Current assets Stemline Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Stemline Therapeutics, Inc. is 133 940 812 $
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-11 990 960 $
-12 074 872 $
-11 758 025 $
-10 684 064 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
17 039 550 $
12 074 872 $
11 758 025 $
11 184 064 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
5 048 590 $
-
-
500 000 $
-
-
299 397 $
299 401 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
5 048 590 $
-
-
500 000 $
-
-
299 397 $
299 401 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-27 944 928 $
-26 927 988 $
-21 405 361 $
-19 306 680 $
-18 646 658 $
-21 938 733 $
-16 270 704 $
-15 660 259 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-27 407 266 $
-26 634 914 $
-21 043 996 $
-18 928 703 $
-18 416 753 $
-21 749 301 $
-16 056 147 $
-15 456 936 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
47 725 019 $
47 725 019 $
47 725 019 $
12 708 058 $
16 725 380 $
12 417 652 $
11 479 030 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
32 993 518 $
26 927 988 $
21 405 361 $
19 806 680 $
18 646 658 $
21 938 733 $
16 570 101 $
15 959 660 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
133 940 812 $
63 058 852 $
80 530 475 $
98 363 932 $
100 605 276 $
52 188 777 $
66 123 635 $
64 557 870 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
136 165 196 $
63 493 570 $
80 964 600 $
99 710 691 $
107 675 604 $
67 006 168 $
80 830 340 $
93 973 551 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
24 014 510 $
9 443 667 $
11 677 741 $
16 909 400 $
15 230 838 $
4 795 098 $
10 265 356 $
8 549 890 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
26 442 720 $
21 218 924 $
17 335 260 $
18 285 640 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
99 507 634 $
51 719 710 $
65 525 279 $
64 085 990 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
27 273 034 $
21 291 515 $
17 426 434 $
18 353 425 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
20.03 %
33.53 %
21.52 %
18.41 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
108 892 162 $
42 202 055 $
63 538 166 $
81 357 266 $
88 017 650 $
47 070 429 $
66 244 151 $
79 973 386 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-22 137 027 $
-18 441 330 $
-18 689 313 $
-17 966 048 $
-17 085 227 $
-13 724 360 $
-13 332 002 $
-12 515 835 $
Last revenue report of Stemline Therapeutics, Inc. was 31/03/2019. According to last financial report total revenue in Stemline Therapeutics, Inc. was 5 048 590 US dollar and changed by -100% since last year. Net income in Stemline Therapeutics, Inc. was -27 407 266 $ in last quartal, net income changes to 0%.
Total assets Stemline Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Stemline Therapeutics, Inc. is 136 165 196 $ Current cash Stemline Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Stemline Therapeutics, Inc. is 24 014 510 $ Current debt Stemline Therapeutics, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Stemline Therapeutics, Inc. is 26 442 720 $
Stemline Therapeutics, Inc. stocks data
STML stock price
Stemline Therapeutics, Inc. stock price today, STML stock quote.
